William C. Zamboni
- Molecular Biology top 2%
- Biomaterials top 0.1%
- Biomedical Engineering top 1%
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Co-authors
- Piotr GrodzinskiAlberto GabizónUma PrabhakarOmid C. FarokhzadSimon T. BarryDavid C. BlakeyHiroshi MaedaEva M. Sevick‐Muraca
- Topics
- Nanoparticle-Based Drug Delivery (70 papers)Cancer therapeutics and mechanisms (57 papers)Lung Cancer Research Studies (34 papers)
- Partner nations
- United StatesNetherlandsIsrael
In The Last Decade
William C. Zamboni
196 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Molecular Biology 3.3k
- Biomaterials 3.1k
- Biomedical Engineering 2.4k
- Oncology 2.4k
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by William C. Zamboni
This map shows the geographic impact of William C. Zamboni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Zamboni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Zamboni more than expected).
Fields of papers citing papers by William C. Zamboni
This network shows the impact of papers produced by William C. Zamboni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Zamboni. The network helps show where William C. Zamboni may publish in the future.
Co-authorship network of co-authors of William C. Zamboni
This figure shows the co-authorship network connecting the top 25 collaborators of William C. Zamboni. A scholar is included among the top collaborators of William C. Zamboni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Zamboni. William C. Zamboni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 98 | |
| 7 | 43 | |
| 8 | 66 | |
| 9 | 53 | |
| 10 | 85 | |
| 11 | 40 | |
| 12 | 107 | |
| 13 | 215 | |
| 14 | DDS製品開発の最前線 Formulation and physiological factors affecting the pharmacokinetics and pharmacodynamics of liposomal anticancer agents | 4 |
| 15 | Evaluation of body surface area (BSA) based dosing, age, and body composition as factors affecting the pharmacokinetic (PK) variability of STEALTH liposomal doxorubicin (Doxil) | 8 |
| 16 | A physiologically-based pharmacokinetic (PBPK) model of docetaxel in SCID mice bearing SKOV3 human ovarian cancer xenografts | 1 |
| 17 | Plasma, tissue and tumor disposition of STEALTH® liposomal CKD-602 (S-CKD602) and non-liposomal CKD-602, a camptothecin analogue, in mice bearing A375 human melanoma xenografts | 3 |
| 18 | Allometric scaling of STEALTH® liposomal anticancer agents | 4 |
| 19 | 118 | |
| 20 | 112 |
About William C. Zamboni
William C. Zamboni is a scholar working on Biomaterials, Oncology and Genetics, having authored 202 papers that have together received 8.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (70 papers), Cancer therapeutics and mechanisms (57 papers) and Lung Cancer Research Studies (34 papers). The work is most often cited by research in Biomaterials (3.1k citations), Oncology (2.4k citations) and Pharmaceutical Science (421 citations). William C. Zamboni has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Piotr Grodzinski, Alberto Gabizón, Uma Prabhakar, Omid C. Farokhzad, Simon T. Barry, David C. Blakey, Hiroshi Maeda, Eva M. Sevick‐Muraca, Rakesh K. Jain and Clinton F. Stewart. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.